AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding....
Q1 2026
Apr 23, 2026
FY 2025
Mar 13, 2026
Q4 2025
Q3 2025
Nov 4, 2025
Q2 2025
Aug 5, 2025